Biocybernetics

Meet Peter 2.0: One step closer to the Singularity

When Dr Peter Scott-Morgan was diagnosed with motor neurone disease, he decided to challenge what it means to be human. “Peter 2.0 is now online.”...

Closed-loop pancreas system aces trial

Tandem and Dexcom system aces closed-loop pancreas trial for type 1 diabetes, but doesn't appear to break new ground over existing market competitor. A clinical...

Closed-loop artificial pancreas slated to drastically improve lifespan

Cambridge University team release patient test results of insulin pump for artificial pancreas and monitoring device powered by AI. Of all of the adjectives that...

Totally artificial heart implant extends life in research breakthrough

Risks of leaving a diseased heart in situ are eliminated after US university team's artificial heart breakthrough. An artificial device implanted in the chest of...

Latest articles

Insurer puts down £20m to research an aging rethink

A new partnership between Legal & General and Edinburgh University aims to address the societal and economic implications of an aging society. The world is...

23andMe redundancies: DNA test market decline?

Could layoffs at 23andMe be a sign that the consumer appetite for genetic testing is declining? We expect consumer markets to transition to more...

Singapore agetech – ones to watch in 2020

Singapore thrives on its prime location at the crossroads of Asia's biggest markets, low business tax and great IT infrastructure; it is well-positioned to...

Innovating organ-on-chip to accelerate research

BIOFABICS brings custom design tools to biofabrication. While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.